In the BioHarmony Drug Report Database

"Preview" Icon

Chlorambucil

Leukeran (chlorambucil) is a small molecule pharmaceutical. Chlorambucil was first approved as Leukeran on 1982-01-01. It is used to treat b-cell chronic lymphocytic leukemia, breast neoplasms, choriocarcinoma, hodgkin disease, and non-hodgkin lymphoma amongst others in the USA.

 

Trade Name

 

Leukeran
 

Common Name

 

chlorambucil
 

ChEMBL ID

 

CHEMBL515
 

Indication

 

b-cell chronic lymphocytic leukemia, breast neoplasms, choriocarcinoma, hodgkin disease, non-hodgkin lymphoma, ovarian neoplasms, testicular neoplasms, thrombocytosis, waldenstrom macroglobulinemia
 

Drug Class

 

Image (chem structure or protein)

Chlorambucil structure rendering